Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance

Arteriosclerosis, Thrombosis, and Vascular Biology
M Cattaneo

Abstract

Aspirin and the thienopyridines ticlopidine and clopidogrel are antiplatelet agents that display good antithrombotic activity. In the past few years, the concept of aspirin resistance has been largely emphasized in the medical literature, although its definition is still uncertain. I suggest that "aspirin-resistant" should be considered as a description for those individuals in whom aspirin fails to inhibit thromboxane A2 production, irrespective of the results of unspecific tests of platelet function, such as the bleeding time, platelet aggregation, or the PFA-100 system. Less well known than aspirin resistance, but certainly better characterized, is the issue of "clopidogrel resistance," which is probably mostly caused by inefficient metabolism of the prodrug clopidogrel to its active metabolite. At present, aspirin and clopidogrel resistance should not be looked for in the clinical setting, because there is no definite demonstration of an association with clinical events conditioning cost-effective changes in patient management.

References

Jun 1, 1975·The American Journal of Physiology·J F MustardM A Packham
Dec 8, 1977·The New England Journal of Medicine·A J Marcus
May 5, 1994·The New England Journal of Medicine·C Patrono
Jun 10, 1998·Annals of Internal Medicine·C L BennettD Green
Jun 27, 1998·Lancet·G E CookeP J Goldschmidt-Clermont
Aug 14, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·J GeigerU Walter
Jun 15, 2000·The New England Journal of Medicine·C L BennettH M Tsai
Nov 10, 2000·BMJ : British Medical Journal·S Derry, Y K Loke
Jul 27, 2001·The American Journal of Cardiology·P A GumE J Topol
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Aug 25, 2001·Lancet·S R MehtaUNKNOWN Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators
Dec 26, 2001·The New England Journal of Medicine·F Catella-LawsonG A FitzGerald
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Bianca RoccaCarlo Patrono
May 29, 2002·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·R E RollerE Pilger
Jun 7, 2002·The New England Journal of Medicine·Jean-Michel GaspozLee Goldman
Jul 30, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids·A CsiszarZ Ungvari
Oct 10, 2002·The American Journal of Cardiology·David C SaneVictor L Serebruany
Nov 19, 2002·JAMA : the Journal of the American Medical Association·Steven R SteinhublUNKNOWN CREDO Investigators. Clopidogrel for the Reduction of Events During Observation
Dec 18, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Thomas A Clarke, Lucy A Waskell
Jan 11, 2003·BMJ : British Medical Journal·Maribeth FriendMichael Miller
Jan 16, 2003·Journal of Neurology·K GrundmannH Topka
Feb 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Marco CattaneoZaverio M Ruggeri
Feb 25, 2003·Lancet·T M MacDonald, L Wei
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·M Cattaneo
Aug 13, 2003·Journal of Thrombosis and Haemostasis : JTH·C Patrono
Aug 28, 2003·Journal of Thrombosis and Haemostasis : JTH·G De Gaetano, C Cerletti
Sep 25, 2003·Archives of Internal Medicine·Rachel S EidelmanCharles H Hennekens

❮ Previous
Next ❯

Citations

Oct 31, 2009·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Chip GreshamAnne-Michelle Ruha
Apr 7, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Christian TemplinMario von Depka
Aug 11, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Karsten SchrörA-A Weber
Oct 17, 2006·Wiener medizinische Wochenschrift·Florian B Mayr, Bernd Jilma
Oct 25, 2006·Pharmaceutical Research·Wei C Lau, Paul A Gurbel
Apr 4, 2007·Journal of Thrombosis and Thrombolysis·Lukasz A MalekGrzegorz Opolski
Jun 28, 2011·Journal of Thrombosis and Thrombolysis·Aldona KubicaAleksander Goch
Apr 13, 2011·Purinergic Signalling·Marco Cattaneo
Apr 17, 2013·Molecular Diagnosis & Therapy·Athanasios Karathanos, Tobias Geisler
Jul 1, 2006·Nature Clinical Practice. Cardiovascular Medicine·Paul A Gurbel, Udaya S Tantry
Dec 21, 2006·Nature Clinical Practice. Cardiovascular Medicine·Carlo Patrono, Bianca Rocca
Dec 2, 2005·The New England Journal of Medicine·Carlo PatronoColin Baigent
Jul 4, 2012·Proceedings of the National Academy of Sciences of the United States of America·Giovanni SitiaLuca G Guidotti
Oct 28, 2008·European Heart Journal·Francisco J Pastor-PérezGregory Y H Lip
Aug 5, 2006·Current Opinion in Hematology·Francesco Violi, Pasquale Pignatelli
Apr 7, 2007·Journal of Cardiovascular Pharmacology·Joseph A JakubowskiKenneth J Winters
Nov 27, 2008·Journal of Cardiovascular Pharmacology·Gabriella PuschLaszlo Szapary
Sep 22, 2007·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Thorsten DrewsRoland Hetzer
Sep 5, 2009·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Huseyin AksuAhmet Narin
Jan 19, 2008·BMJ : British Medical Journal·George KrasopoulosMichael R Buchanan
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·Christian Gachet
Jul 16, 2005·Cardiology·Tina Svenstrup PoulsenHans Mickley
Mar 20, 2008·Cerebrovascular Diseases·Cathy M HelgasonLarry D Brace
May 6, 2011·Thrombosis and Haemostasis·H FernandoJ A Shaw
Feb 22, 2013·Thrombosis and Haemostasis·M Cattaneo
Dec 17, 2009·Hematology·David Varon, Galia Spectre
Jul 18, 2008·Anesthesia and Analgesia·Lisa T NewsomeRoger L Royster
Jul 18, 2008·Anesthesia and Analgesia·Lisa T NewsomeRoger L Royster
Mar 19, 2011·Biological & Pharmaceutical Bulletin·Yuuki AkagiTakao Aoyama
Aug 17, 2005·American Journal of Clinical Pathology·Stewart M Knoepp, Michael Laposata
Jun 17, 2006·Internal Medicine·Shunichiro FuchigamiHisao Ogawa
May 1, 2006·Future Cardiology·Dalton S McLean, Christopher P Cannon
Sep 1, 2005·Future Cardiology·Daniel C Bezerra, Julien Bogousslavky
Sep 3, 2013·Antioxidants & Redox Signaling·Francesco Violi, Pasquale Pignatelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.